Evidence map›Paper›PMID 36291701›Full record

ArticleBiomolecules2022

Comparative Analysis of Mesophilic YqfB-Type Amidohydrolases.

Roberta Statkevičiūtė, Mikas Sadauskas, Juta Rainytė, Karolina Kavaliauskaitė, Rolandas Meškys

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Roberta StatkevičiūtėDepartment of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.
Mikas SadauskasDepartment of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.ORCID 0000-0001-9072-6523
Juta RainytėDepartment of Eukaryote Gene Engineering, Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.ORCID 0000-0003-1910-1509
Karolina KavaliauskaitėDepartment of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.
Rolandas MeškysDepartment of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.ORCID 0000-0003-3125-9827
Vilnius University · LT

Funding

A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS TrialR01AG071803 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ALLON, MICHAEL, MUREA, MARIANA · 2021 to 2025
$5.6M
6 · The paper itself

Abstract

The widespread superfamily of the human activating signal cointegrator homology (ASCH) domain was identified almost 20 years ago; however, the amount of experimental data regarding the biological function of the domain is scarce. With this study, we aimed to determine the putative cellular functions of four hypothetical ASCH domain-containing amidohydrolase YqfB analogues by investigating their activity towards various

Indexed as

AmidohydrolasesProdrugsCytosineHumansNucleosidesProteinsPyrimidinesSubstrate SpecificityAmidohydrolasesCytosineNucleosidesProdrugsProteinsPyrimidinesamidohydrolaseASCHN4-acetylcytidineprodrug

Identifiers

PMID36291701
PMCPMC9599836
OpenAlexW4306362104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.